Answer Facts
General information, not medical advice. By the Calco Editorial Team.
On this page
Short Answer: Not Approved for Insulin Resistance, but It Can Affect It
Mounjaro is the brand name of tirzepatide, a once-weekly injection. The FDA approved it to be used with diet and exercise to improve blood sugar in adults with type 2 diabetes[3]. It is not approved as a treatment for insulin resistance or prediabetes by itself.
The same active ingredient is sold as Zepbound. Zepbound is approved for chronic weight management in adults with obesity, or with overweight and at least one weight-related condition, together with a reduced-calorie diet and more physical activity[3]. It is also approved to treat obstructive sleep apnea in adults with obesity[2].
In clinical trials, tirzepatide lowered blood sugar and body weight. Studies also report better markers of insulin sensitivity. Much of this effect is probably linked to weight loss, which is one of the main ways to improve insulin resistance[1].
How Tirzepatide Works
Tirzepatide activates the receptors for two gut hormones: GLP-1 and GIP. Both hormones are released after a meal. According to the FDA, this action reduces appetite and food intake[3]. Other known effects include:
- It helps the pancreas release insulin when blood sugar is high.
- It lowers glucagon, a hormone that raises blood sugar.
- It slows how fast food leaves the stomach.
Researchers are still studying how much of the benefit comes from the GIP action and how much comes from weight loss.
What the Research Shows
- Type 2 diabetes (SURPASS trials): Tirzepatide lowered A1C and body weight more than placebo. In one head-to-head trial it lowered A1C more than semaglutide 1 mg.
- Obesity (SURMOUNT trials, Zepbound): In the larger trial of adults without diabetes, people on the highest approved dose lost on average 18% of their body weight compared with people on placebo, after 72 weeks[3].
- Insulin sensitivity markers: Analyses of trial data report lower fasting insulin and better HOMA-IR scores. These are measures used in research, not a diagnosis.
- Insulin resistance without diabetes: No FDA approval covers insulin resistance as a condition on its own.
Results vary from person to person. Weight and blood sugar often rise again after the medicine is stopped.
Mounjaro and Similar Medicines
This table lists the main FDA-approved uses. It does not compare how well the medicines work.
| Medicine | Active ingredient | Main approved use |
|---|---|---|
| Mounjaro | tirzepatide | Type 2 diabetes |
| Zepbound | tirzepatide | Chronic weight management; sleep apnea with obesity |
| Ozempic | semaglutide | Type 2 diabetes |
| Wegovy | semaglutide | Chronic weight management |
| Metformin (generic) | metformin | Type 2 diabetes |
Side Effects and Safety
The most common side effects are nausea, diarrhea, vomiting, constipation, stomach pain, and lower appetite. They are often worse when the dose goes up. The prescribing information also lists serious risks[2]:
- A possible risk of thyroid tumors, including a type of thyroid cancer. These tumors occurred in rats. It is not known if the risk applies to people. People with a personal or family history of medullary thyroid cancer or MEN 2 should not use it.
- Inflammation of the pancreas (pancreatitis).
- Gallbladder problems.
- Low blood sugar, mostly when used with insulin or sulfonylureas.
- Kidney problems, often linked to dehydration.
- Serious allergic reactions.
Tirzepatide may make hormonal birth control less effective. Your doctor may suggest another type of birth control for 4 weeks after you start and after each dose change[2].
Call your doctor right away if you have severe stomach pain, a lump or swelling in the neck, trouble swallowing, or signs of an allergic reaction.
Lifestyle Habits Still Matter
Tirzepatide is approved for use together with diet and exercise. NIH guidance for insulin resistance focuses on these habits[1]:
- Eat a healthy diet with vegetables, fruit, whole grains, lean protein, and fewer sugary drinks and refined foods.
- Be physically active on most days. Include some strength training to help keep muscle while you lose weight.
- Get enough sleep and do not smoke.
- Drink enough fluids, especially if you have stomach side effects.
To estimate a daily protein target while you take a GLP-1 medicine, use the GLP-1 protein calculator. For meal ideas, see the 7-day GLP-1 meal plan. Ask your doctor or dietitian before you change your diet.
Questions to Ask Your Doctor
- Do my test results show insulin resistance, prediabetes, or type 2 diabetes?
- Is tirzepatide right for me, or should I start with lifestyle changes or another medicine?
- Which side effects should I watch for, and when should I call you?
- How will we check if the treatment works, and what happens if I stop?
Sources
Frequently asked questions
Does Mounjaro work against insulin resistance?
Mounjaro (tirzepatide) is FDA-approved, with diet and exercise, to improve blood sugar in adults with type 2 diabetes. It is not approved to treat insulin resistance on its own. In clinical trials it lowered A1C and body weight, and studies report better markers of insulin sensitivity, much of it linked to weight loss. The same medicine is sold as Zepbound for chronic weight management. Talk to your doctor about whether it is right for you.
Medical disclaimer: This page is for general information and is not medical advice. Talk to your doctor before changing your diet or medication. Read our editorial policy.
